Scientific paper - Original scientific paper
Interleukin-17 and Toll-like Receptor 10 genetic polymorphisms and susceptibility to large joint osteoarthritis
Journal of Orthopaedic Research®, 36 (2017), 6; 1684-1693. https://doi.org/10.1002/jor.23823

Vrgoč, Goran; Vrbanec, Jurica; Eftedal, Randi K.; Dembić, Petra L.; Balen, Sanja; Dembić, Zlatko; Jotanović, Zdravko

Cite this document

Vrgoč, G., Vrbanec, J., Eftedal, R. K., Dembić, P. L., Balen, S., Dembić, Z. & Jotanović, Z. (2017). Interleukin-17 and Toll-like Receptor 10 genetic polymorphisms and susceptibility to large joint osteoarthritis. Journal of Orthopaedic Research®, 36. (6), 1684-1693. doi: 10.1002/jor.23823

Vrgoč, Goran, et al. "Interleukin-17 and Toll-like Receptor 10 genetic polymorphisms and susceptibility to large joint osteoarthritis." Journal of Orthopaedic Research®, vol. 36, no. 6, 2017, pp. 1684-1693. https://doi.org/10.1002/jor.23823

Vrgoč, Goran, Jurica Vrbanec, Randi K. Eftedal, Petra L. Dembić, Sanja Balen, Zlatko Dembić and Zdravko Jotanović. "Interleukin-17 and Toll-like Receptor 10 genetic polymorphisms and susceptibility to large joint osteoarthritis." Journal of Orthopaedic Research® 36, no. 6 (2017): 1684-1693. https://doi.org/10.1002/jor.23823

Vrgoč, G., et al. (2017) 'Interleukin-17 and Toll-like Receptor 10 genetic polymorphisms and susceptibility to large joint osteoarthritis', Journal of Orthopaedic Research®, 36(6), pp. 1684-1693. doi: 10.1002/jor.23823

Vrgoč G, Vrbanec J, Eftedal RK, Dembić PL, Balen S, Dembić Z, and sur.. Interleukin-17 and Toll-like Receptor 10 genetic polymorphisms and susceptibility to large joint osteoarthritis. Journal of Orthopaedic Research® [Internet]. 2017 [cited 2024 April 28];36(6):1684-1693. doi: 10.1002/jor.23823

G. Vrgoč, et al., "Interleukin-17 and Toll-like Receptor 10 genetic polymorphisms and susceptibility to large joint osteoarthritis", Journal of Orthopaedic Research®, vol. 36, no. 6, pp. 1684-1693, 2017. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:358497. [Accessed: 28 April 2024]